Osteoarthritis

Synovitis scoring in hand osteoarthritis with ultrasonography: the performance of the Global OMERACT/EULAR Ultrasound Synovitis Score (GLOESS) is comparable to synovial thickening alone

RMD OpenPublished Secondary analysis of the Hand Osteoarthritis Prednisolone Efficacy (HOPE) randomised trial

Authors' conclusion

The GLOESS and synovial thickening were both responsive to treatment, but GLOESS was not superior to synovial thickening alone.

Study context

Population
Patients with painful, inflammatory hand OA in the HOPE trial; ultrasound of 30 hand joints at weeks 0, 6 and 1479% women
Participants
92 patients
Comparison
Prednisolone vs placebo; ultrasound synovitis scores
Methodological detailsdouble-blinded, Generalised estimating equations; effect sizes calculated
  • Double-blinded
  • Generalised estimating equations; effect sizes calculated

Primary result

As reported in the abstract

Responsiveness of US scores to treatment (prednisolone vs placebo)
  • All US scores strongly associated with joint tenderness and soft swelling cross-sectionally
  • No association of change in US scores with change in tenderness, but there was with change in soft tissue swelling
  • GLOESS not superior to synovial thickening alone

Further findings

Synovial thickening was the most prevalent
All ultrasound scores strongly associated with joint tenderness and soft swelling cross-sectionally
No association of change in ultrasound scores with change in tenderness
Change in ultrasound scores associated with change in soft tissue swelling

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Synovitis scoring in hand osteoarthritis with ultrasonography: the performance of the Global OMERACT/EULAR Ultrasound Synovitis Score (GLOESS) is comparable to synovial thickening alone. RMD Open. Published 31 December 2024. doi:10.1136/rmdopen-2024-005002

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.